Home intravenous antibiotics for cystic fibrosis

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2008, Pages

  Balaguer, Albert ^a   González De Dios, Javier ^b  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b HOSPITAL DE TORREVIEJA   (Spain)

Author keywords

*Home care services; Anti bacterial agents *administration dosage ; Cystic fibrosis *complications ; Injections, intravenous; Randomized controlled trials as topic; Respiratory tract infections *drug therapy; etiology

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CEFTAZIDIME; CREATININE; TOBRAMYCIN;

ANOREXIA; ANTIBIOTIC THERAPY; AUDIOLOGY; BLOATING; BREATHING EXERCISE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; CYSTIC FIBROSIS; DIABETES MELLITUS; DISEASE EXACERBATION; DRUG COST; DYSPNEA; EMOTIONALITY; FATIGUE; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL SYMPTOM; HEALTH CARE COST; HEMOPTYSIS; HOME CARE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INFECTION; INTESTINE OBSTRUCTION; LUNG FUNCTION; LUNG INFECTION; MORTALITY; NUTRITIONAL REQUIREMENT; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PNEUMOTHORAX; PRURITUS; PSEUDOMONAS AERUGINOSA; PULSE OXIMETRY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SPIROMETRY; SYSTEMATIC REVIEW; THROMBOPHLEBITIS; TREATMENT DURATION; URTICARIA; WALKING; WEIGHT GAIN;

EID: 55049116703     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001917.pub2     Document Type: Review

References (38)

1. Wolter 1997 {published data only} Wolter J, Bowler S, Nolan P, McCormack J. Intravenous home therapy: a randomised trial in adult cystic fibrosis patients [abstract]. Australian & New Zealand Journal of Medicine 1995;25:567.
2. * Wolter JM, Bowler SD, Nolan PJ, McCormack JG. Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects. European Respiratory Journal 1997;10(4):896-900.
3. Amelina 2000 {published data only} Amelina E, Senkevich N, Cherniak A, Cherniaev A, Chuchalin A. Home intravenous therapy in adult cystic fibrosis patients. The impact on lung fuction and quality of life [abstract]. European Respiratory Journal 2000;Suppl 31:123s.
4. Bosworth 1997 {published data only} Bosworth DG, Nielson DW. Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis. Pediatric Pulmonology 1997;24(1):42-7.
5. Davis 1990 {published data only} Davis S, Mather F, Tankersly P, Waring W, The Home IV Antibiotic Study Group. A randomized trial of home intravenous antibiotic therapy (HIVAT) in Cystic Fibrosis (CF): Short-Term Safety and efficacy [abstract]. Pediatric Pulmonology 1990;Suppl 5:207.
6. * Davis S, Mather F, Waring W, The Home IV Antibiotic Study Group. A randomized trial of home intravenous antibiotic therapy (HIVAT) in Cystic Fibrosis (CF): Short-Term psychological effects [abstract]. Pediatric Pulmonology 1990;Suppl 5:338.
7. Donati 1987 {published data only} Donati MA, Guenette G, Auerbach H. Prospective controlled study of home and hospital therapy of cystic fibrosis pulmonary disease. Journal of Pediatrics 1987;111(1):28- 33.
8. Esmond 2006 {published data only} Esmond G, Butler M, McCormack AM. Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis. Journal of Clinical Nursing 2006;15(1):52-60. [MEDLINE: 16390524]
9. Girón 2004 {published data only} Girón RM, Martínez A, Máiz L, Salcedo A, Beltrán B, Martínez MT, et al.Home intravenous antibiotic treatments in cystic fibrosis units of Madrid. Medicina clínica 2004;122(17):648-52. [MEDLINE: 15153343]
10. Girón 2006 {published data only} Girón RM, Cisneros C, Nakeeb ZA, Hoyos N, Martínez C, Ancochea J. Efficiency of the home intravenous antibiotics treatment in cystic fibrosis. Medicina clínica 2006;127(15):567-71. [MEDLINE: 17145013]
11. Graf 1997 {published data only} * Graf von der Schulenburg JM, Greiner W, Klettke U, Wahn U. Economic aspects in treatment of cystic fibrosis with chronic pulmonary pseudomonas infection. Ambulatory intarvenous therapy in comparison with inpatient treatment [Ökonomische Aspekte der Behandlung zysticher Fibrose mit chronischer pulmonaler Pseudomonasinfektion. Ambulante intravenöse Therapie im Vergleich zur stationären Behandlung]. Medizinische Klinik 1997;92(10):626- 9.
12. Klettke U, Maagdorf K, Staab D, Paul K, Wahn U. Ambulatory vs. inpatient intravenous antibiotic therapy in mucoviscidosis patients - a controlled study. Pneumologie 1999;53(1):31-6.
13. Magdorf K, Klettke U, Staab D, Paul K, Wahn U. Home intravenous antibiotic therapy vs. hospital therapy - an alternative for patients with cystic fibrosis?. Monatsschrift Fur Kinderheilkunde 1996;144:1047.
14. Horvais 2006 {published data only} Horvais V, Touzet S, François S, Bourdy S, Bellon G, Colin C, et al.Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France. International journal of technology assessment in health care 2006;22(4):525-31. [MEDLINE: 16984688]
15. Nazer 2006 {published data only} Nazer D, Abdulhamid I, Thomas R, Pendleton S. Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis. Pediatric Pulmonology 2006;41 (8):744-9. [MEDLINE: 16779852]
16. Ramström 2000 {published data only} Ramström H, Erwander I, Mared L, Kornfält R, Seiving B. Pharmaceutical intervention in the care of cystic fibrosis patients. Journal of Clinical Pharmacy and Therapeutics 2000;25(6):427-34.
17. Riethmueller 2002 {published data only} Riethmueller J, Busch A, Damm V, Ziebach R, Stern M. Home and hospital antibiotic treatment prove similarly effective in cystic fibrosis. Infection 2002;30(6):387-91. [MEDLINE: 12478330]
18. Romano 1991 {published data only} Romano L, Girosi D, Spallone E, Parisi L, Minucci L, Romano C. Ofloxacin in the treatment of cystic fibrosis [Uso dell'ofloxacin nei pazienti con fibrosis cistica]. Minerva Pediatrica 1992;44(3):79-86.
19. * Romano L, Minicucci L, Spallone E, Girosi D, Campelli A, Fabbri A, et al.Role of home therapy with ofloxacin in patients with cystic fibrosis (CF) [Ruolo della terapia domiciliare con ofloxacin in pazienti con fibrosi cistica (FC)]. Giornale Italiano de Chemioterapia 1991;38(13):181- 3.
20. Thornton 2005 {published data only} Elliott RA, Thornton J, Webb AK, Dodd M, Tully MP. Comparing costs of home- versus hospital-based treatment of infections in adults in a specialist cystic fibrosis center. International journal of technology assessment in health care 2005;21(4):506-10.
21. Thornton J, Elliott R, Tully MP, Dodd M, Webb AK. Free Full TextLong term clinical outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis. Thorax 2004;59(3):242-6. [MEDLINE: 14985563]
22. * Thornton J, Elliott RA, Tully MP, Dodd M, Webb AK. Clinical and economic choices in the treatment of respiratory infections in cystic fibrosis: comparing hospital and home care. Journal of Cystic Fibrosis 2005;4(4):239-47. [MEDLINE: 16242385]
23. Wolter 2004 {published data only} Wolter JM, Cagney RA, McCormack JG. A randomized trial of home vs hospital intravenous antibiotic therapy in adults with infectious diseases. Journal of Infection 2004;48(3):263-8. [MEDLINE: 15001305]
24. Hjelte 1988 {published data only} Hjelte L, Widen B, Malmborg AS, Freyschuss U, Strandvik B. [Intravenous administration of antibiotics at home in patients with cystic fibrosis improves quality of life] [Intravenos antibiotikabehandling i hemmet vid cystisk fibros ger okad livskvalitet]. Lakartidningen 1988, issue 18:1614-7.
25. David 1986 David TJ. Intravenous antibiotics at home in children with cystic fibrosis. Journal of the Royal Society of Medicine 1986;82(3):130-1.
26. Davis 1996 Davis PB, Drumm M, Konstan MW. Cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 1996;154(5):1229-56.
27. DeMets 1987 DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341-50.
28. DerSimonian 1986 DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
29. Egger 1997 Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629-34.
30. Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency inmeta-analyses. BMJ 2003;327(7414):557- 60. [MEDLINE: 12958120]
31. Jones 2003 Jones AM, Webb AK. Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and pandoraea spp. Journal of the Royal Society of Medicine 2003;96(Suppl 43):66-72.
32. Jüni 2001 Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-6. [MEDLINE: 11440947]
33. Kosorok 1996 Kosorok MR, Wei WH, Farrell TM. The incidence of cystic fibrosis. Statistics in Medicine 1996;15(5):449-62.
34. Macaskill 2001 Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-analysis. Statistics in Medicine 2001;20(4):641-54.
35. Pond 1994 Pond MN, Newport M, Joanes D, Conway SP. Home versus hospital intravenous antibiotic therapy in the treatment of young adults with cystic fibrosis. European Respiratory Journal 1994;7(9):1640-4.
36. Rucker 1974 Rucker RW, Harrison GM. Outpatient intravenous medication in the management of cystic fibrosis. Pediatrics 1974;54(3):358-60.
37. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions ofmethodological quality associated with estimates of treatment in controlled trials. Journal of the American Medical Association 1995;273(5):408-12.
38. Strandvik 1992 Strandvik B, Hjelte L, Malmborg AS, Widen B. Home intravenous antibiotic treatment of patients with cystic fibrosis. Acta Paediatrica 1992;81(4):340-4.